Pages that link to "Q27488198"
Jump to navigation
Jump to search
The following pages link to Temporal Dynamics of a Predominant Protease Inhibitor–Resistance Mutation in a Treatment-Naive, Hepatitis C Virus–Infected Individual (Q27488198):
Displaying 8 items.
- Deep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipients (Q28534965) (← links)
- Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China (Q28552134) (← links)
- Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. (Q35061753) (← links)
- Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran (Q36278496) (← links)
- Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment. (Q37615174) (← links)
- Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing (Q39663398) (← links)
- Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors (Q43040477) (← links)
- Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b (Q43046741) (← links)